Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazoprevir + Elbasvir in Liver Transplant Recipients
NCT02890719Phase 3Withdrawn
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Aug 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of grazoprevir, elbasvir in hepatitis C (HCV), sponsored by Fundació Clínic per a la Recerca Biomèdica. Planned start Aug 2016; status: withdrawn.
02
Drugs
grazoprevirelbasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02890719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02890719.